FDA updates reports of squamous cell carcinoma in capsule around breast implants

Editor's Note

The Food and Drug Administration (FDA), on March 8, issued an update on reports of squamous cell carcinoma in the scar tissue (capsule) that forms around breast implants—both saline and silicone as well as textured and smooth.

Previously, on September 8, 2022, the FDA informed the public of reports of cancers, including squamous cell carcinomas and various lymphomas, found in the capsule.

The FDA is aware of 19 cases of squamous cell carcinomas, and there have been reports in the literature of deaths from progression of the disease.

Although the FDA says it continues to believe the occurrences of squamous cell carcinoma in the capsule may be rare, the cause, incidence, and risk factors remain unknown.